Have a personal or library account? Click to login
IGHV Mutational Status in a Cohort of Bulgarian CLL Patients: High Unmutated CLL Prevalence in North-East Bulgaria Cover

IGHV Mutational Status in a Cohort of Bulgarian CLL Patients: High Unmutated CLL Prevalence in North-East Bulgaria

Open Access
|Sep 2024

References

  1. Rajendra ND, Tarun W, Franco F et al. Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia, Blood, Volume 94, Issue 6, 1999, Pages 1840–1847.
  2. Sutton, L. A., et al. Immunoglobulin genes in chronic lymphocytic leukemia: Key to understanding the disease and improving risk stratification. Haematologica. 102 (6), 968–971 (2017).
  3. Ten Hacken E, Gounari M, Ghia P et al. The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia. Leukemia. 2019 Feb;33(2):287–298. doi: 10.1038/s41375-018-0303-x. Epub 2018 Dec 16. PMID: 30555163; PMCID: PMC7182338.
  4. Schroeder HW Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S41–52. doi: 10.1016/j.jaci.2009.09.046. PMID: 20176268; PMCID: PMC3670108
  5. Calis JJ, Rosenberg BR. Characterizing immune repertoires by high throughput sequencing: strategies and applications. Trends Immunol. 2014;35(12):581–590.
  6. Agathangelidis A, Chatzidimitriou A, Chatzikonstantinou T et al. Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL. Leukemia 2022; 36, 1961–1968.
  7. Huet, Sarah & Bouvard, Anne & Ferrant, Emmanuelle & Mosnier, Isabelle & Chabane, Kaddour & Salles, Gilles & Michallet, Anne-Sophie & Hayette, Sandrine & Sujobert, Pierre. (2020). Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia. Leukemia. 34. 10.1038/s41375-020-0716-1.
  8. Agathangelidis A, Sutton LA, Hadzidimitriou A et al. Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation. 2018 J. Vis. Exp. (141)
  9. Matthews C, Catherwood M, Morris TC et al. Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols. Leuk Lymphoma. 2004 Sep;45(9):1899–904.
  10. Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W503–8.
  11. Jain P, Nogueras Gonzalez GM, Kanagal-Shamanna R. The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab. Br J Haematol. 2018; 180(1):33–40.
  12. Darzentas N. ARResT/Interrogate Immunoprofiling Platform: Concepts, Workflows, and Insights. 2022 May 28. In: Langerak AW, editor. Immunogenetics: Methods and Protocols [Internet]. New York: Humana; 2022. Chapter 26. Available from: https://www.ncbi.nlm.nih.gov/books/NBK586953/ doi: 10.1007/978-1-0716-2115-8_26;
  13. Bystry V, Agathangelidis A, Bikos V et al, also on behalf of ERIC, the European Research Initiative on CLL, ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy, Bioinformatics, Volume 31, Issue 23, December 2015, Pages 3844–3846,
  14. Gaidano G, Rossi D. The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):329–337. doi: 10.1182/asheducation-2017.1.329. PMID: 29222275; PMCID: PMC6142556.
  15. Hanson C. GHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL). Available from: https://news.mayocliniclabs.com/2019/08/12/ighv-and-tp53-sequencing-clinical-utility-in-chronic-lymphocytic-leukemia-cll
  16. Plevova K, Francova HS, Burckova K et al. Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clones. Haematologica. 2014 Feb;99(2):329–38.
  17. Rotbain EC, Frederiksen H, Hjalgrim H, et al. IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study. Haematologica. 2020 Jun;105(6):1621–1629
  18. Gemenetzi K, Agathangelidis A, Zaragoza-Infante L et al. B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making; Frontiers in Oncology 10, 2020;
Language: English
Page range: 15 - 19
Published on: Sep 6, 2024
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2024 A Yosifova, I Micheva, M Donchev, S Tincheva, S Ormandjiev, J Genova, Z Pavlova, A Todorova, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.